95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-4.91%
Negative revenue growth while NEM stands at 15.10%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-5.35%
Negative gross profit growth while NEM is at 11.25%. Joel Greenblatt would examine cost competitiveness or demand decline.
-3.96%
Negative EBIT growth while NEM is at 30.17%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-3.96%
Negative operating income growth while NEM is at 30.17%. Joel Greenblatt would press for urgent turnaround measures.
-8.80%
Negative net income growth while NEM stands at 27.39%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-9.52%
Negative EPS growth while NEM is at 28.21%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-9.52%
Negative diluted EPS growth while NEM is at 27.27%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.02%
Share change of 0.02% while NEM is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.03%
Diluted share reduction more than 1.5x NEM's 0.60%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
0.02%
Dividend growth under 50% of NEM's 49.49%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
-0.62%
Negative OCF growth while NEM is at 206.07%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-82.43%
Negative FCF growth while NEM is at 342.72%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
56.04%
10Y revenue/share CAGR under 50% of NEM's 156.37%. Michael Burry would suspect a lasting competitive disadvantage.
176.47%
5Y revenue/share CAGR 1.25-1.5x NEM's 126.82%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
229.79%
3Y revenue/share CAGR above 1.5x NEM's 81.16%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
12196.64%
10Y OCF/share CAGR above 1.5x NEM's 358.43%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
268.99%
5Y OCF/share CAGR at 50-75% of NEM's 410.53%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
426.39%
3Y OCF/share CAGR at 75-90% of NEM's 482.36%. Bill Ackman would press for improvements in margin or overhead to catch up.
10696.01%
Net income/share CAGR above 1.5x NEM's 942.25% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
273.92%
5Y net income/share CAGR above 1.5x NEM's 126.81%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
367.76%
3Y net income/share CAGR above 1.5x NEM's 137.22%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
2022.77%
10Y equity/share CAGR above 1.5x NEM's 276.53%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
155.80%
5Y equity/share CAGR above 1.5x NEM's 39.72%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
97.53%
3Y equity/share CAGR above 1.5x NEM's 57.74%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
39.73%
Our AR growth while NEM is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
No Data
No Data available this quarter, please select a different quarter.
-1.66%
Negative asset growth while NEM invests at 1.75%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.38%
Positive BV/share change while NEM is negative. John Neff sees a clear edge over a competitor losing equity.
-7.69%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
0.94%
We expand SG&A while NEM cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.